Literature DB >> 22862969

Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.

Kingo Kashimoto1, Shuhei Komatsu, Daisuke Ichikawa, Tomohiro Arita, Hirotaka Konishi, Hiroaki Nagata, Hiroki Takeshita, Yukihisa Nishimura, Shoji Hirajima, Tsutomu Kawaguchi, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Hitoshi Tsuda, Eigo Otsuji.   

Abstract

Recent studies have shown that some members of the tripartite motif-containing protein (TRIM) family, which is characterized by a conserved RING finger, B-box, and coiled-coil domains, function as important regulators for carcinogenesis. In this study, we tested whether TRIM44 (11p13) acts as a cancer-promoting gene through overexpression in gastric cancer. We analyzed seven gastric cancer cell lines and 112 primary tumors, which were curatively resected in our hospital between 2001 and 2003. Expression of the TRIM44 protein was detected in gastric cancer cell lines (2/7 cell lines; 29%) and primary tumor samples of gastric cancer (29/112 cases; 25%). Knockdown of TRIM44 expression using several specific siRNAs inhibited the proliferation, migration, and invasion of TRIM44-overexpressing cells. Overexpression of the TRIM44 protein was significantly correlated with an advanced type of macroscopic appearance, lymphatic invasion, and higher recurrence rate. TRIM44-overexpressing tumors had a worse overall rate of survival than those with non-expressing tumors (P = 0.0038, log-rank test) in both intensity and proportion expression-dependent manner. TRIM44 positivity was independently associated with worse outcome in multivariate analysis (P = 0.0233, hazard ratio 3.37 [1.18-9.64]). These findings suggest that TRIM44 plays a crucial role in tumor cell proliferation through its overexpression, and highlight its usefulness as a predictor and potential therapeutic target in gastric cancer.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22862969     DOI: 10.1111/j.1349-7006.2012.02407.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  36 in total

1.  High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.

Authors:  Xinghua Zhu; Yaxun Wu; Xiaobing Miao; Chunsun Li; Haibing Yin; Shuyun Yang; Xiaoyun Lu; Yushan Liu; Yali Chen; Rong Shen; Xudong Chen; Song He
Journal:  Tumour Biol       Date:  2016-09-12

2.  Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway.

Authors:  Qingquan Luo; Hao Lin; Xiangyun Ye; Jia Huang; Shun Lu; Lin Xu
Journal:  Int J Clin Oncol       Date:  2014-10-28       Impact factor: 3.402

3.  TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway.

Authors:  Xia Zhou; Yadong Yang; Pengcheng Ma; Na Wang; Dong Yang; Qiu Tu; Bin Sun; Tingxiu Xiang; Xudong Zhao; Zongliu Hou; Xiangdong Fang
Journal:  J Neurooncol       Date:  2019-10-11       Impact factor: 4.130

Review 4.  TRIM family contribute to tumorigenesis, cancer development, and drug resistance.

Authors:  Ning Huang; Xiaolin Sun; Peng Li; Xin Liu; Xuemei Zhang; Qian Chen; Hong Xin
Journal:  Exp Hematol Oncol       Date:  2022-10-19

5.  Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma.

Authors:  Jie Chao; Xiao-Fei Zhang; Qiu-Zhong Pan; Jing-Jing Zhao; Shan-Shan Jiang; Ying Wang; Jian-Hua Zhang; Jian-Chuan Xia
Journal:  Med Oncol       Date:  2014-07-04       Impact factor: 3.064

6.  Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer.

Authors:  Yusuke Takashima; Shuhei Komatsu; Takuma Ohashi; Jun Kiuchi; Hajime Kamiya; Hiroki Shimizu; Tomohiro Arita; Hirotaka Konishi; Atsushi Shiozaki; Takeshi Kubota; Kazuma Okamoto; Hitoshi Fujiwara; Hitoshi Tsuda; Eigo Otsuji
Journal:  Cancer Sci       Date:  2022-04-01       Impact factor: 6.518

7.  Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.

Authors:  S Komatsu; D Ichikawa; S Hirajima; H Nagata; Y Nishimura; T Kawaguchi; M Miyamae; W Okajima; T Ohashi; H Konishi; A Shiozaki; H Fujiwara; K Okamoto; H Tsuda; I Imoto; J Inazawa; E Otsuji
Journal:  Br J Cancer       Date:  2014-10-16       Impact factor: 7.640

8.  TRIM44 mediated p62 deubiquitination enhances DNA damage repair by increasing nuclear FLNA and 53BP1 expression.

Authors:  Lin Lyu; Tsung-Chin Lin; Nami McCarty
Journal:  Oncogene       Date:  2021-07-01       Impact factor: 9.867

Review 9.  Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance.

Authors:  Huizhen Wang; Yida Lu; Mingliang Wang; Youliang Wu; Xiaodong Wang; Yongxiang Li
Journal:  J Mol Med (Berl)       Date:  2021-01-03       Impact factor: 4.599

10.  Circular RNA circWDR27 Promotes Papillary Thyroid Cancer Progression by Regulating miR-215-5p/TRIM44 Axis.

Authors:  Weilan Wang; Chengmin Huang; Peng Luo; Jiang Yao; Jie Li; Wenxia Wang; Fengqin Liu
Journal:  Onco Targets Ther       Date:  2021-05-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.